Stock listing
KRX:291650 Aptamer Sciences, Inc. (츌립앤사이언스) 주가
Follow Aptamer Sciences, Inc. into a list and get an email when it puts out news.
Share price · KRX:291650
₩2,170.00 KRW -10.00 (-0.5%)
Close on Nov 20, 2026
- Day range
- ₩2,045.00 – ₩2,170.00 KRWNov 20, 2026
- Volume
- 15,926 sharesNov 20, 2026
- Market cap
- ₩66.23B KRWAt the close on Nov 20, 2026 · price × 30.52M shares outstanding
- 52-week range
- ₩1,350.00 – ₩3,996.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩111.5M KRWMedian day 36,108 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:291650 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩2,170.00 | -10.00 | -0.5% | ₩2,135.00 | ₩2,170.00 | ₩2,045.00 | 15,926 | |
| ₩2,180.00 | 0.00 | 0.0% | ₩2,180.00 | ₩2,200.00 | ₩2,100.00 | 14,242 | |
| ₩2,180.00 | -55.00 | -2.5% | ₩2,130.00 | ₩2,235.00 | ₩2,030.00 | 39,748 | |
| ₩2,235.00 | 0.00 | 0.0% | ₩2,235.00 | ₩2,325.00 | ₩2,015.00 | 56,650 | |
| ₩2,235.00 | +20.00 | +0.9% | ₩2,315.00 | ₩2,315.00 | ₩2,200.00 | 18,862 | |
| ₩2,215.00 | +5.00 | +0.2% | ₩2,175.00 | ₩2,295.00 | ₩2,155.00 | 16,032 | |
| ₩2,210.00 | +40.00 | +1.8% | ₩2,190.00 | ₩2,300.00 | ₩2,190.00 | 66,934 | |
| ₩2,170.00 | -60.00 | -2.7% | ₩2,275.00 | ₩2,325.00 | ₩2,170.00 | 62,382 | |
| ₩2,230.00 | -155.00 | -6.5% | ₩2,500.00 | ₩2,500.00 | ₩2,175.00 | 49,758 | |
| ₩2,385.00 | -85.00 | -3.4% | ₩2,305.00 | ₩2,485.00 | ₩2,305.00 | 69,107 | |
| ₩2,470.00 | -15.00 | -0.6% | ₩2,545.00 | ₩2,620.00 | ₩2,400.00 | 78,657 | |
| ₩2,485.00 | -175.00 | -6.6% | ₩2,660.00 | ₩2,660.00 | ₩2,480.00 | 57,141 | |
| ₩2,660.00 | +20.00 | +0.8% | ₩2,775.00 | ₩2,775.00 | ₩2,550.00 | 68,863 | |
| ₩2,640.00 | +265.00 | +11.2% | ₩2,375.00 | ₩2,735.00 | ₩2,375.00 | 215,201 | |
| ₩2,375.00 | +75.00 | +3.3% | ₩2,295.00 | ₩2,475.00 | ₩2,225.00 | 29,709 | |
| ₩2,300.00 | -10.00 | -0.4% | ₩2,310.00 | ₩2,435.00 | ₩2,220.00 | 36,306 | |
| ₩2,310.00 | -75.00 | -3.1% | ₩2,380.00 | ₩2,430.00 | ₩2,265.00 | 38,403 | |
| ₩2,385.00 | -15.00 | -0.6% | ₩2,595.00 | ₩2,610.00 | ₩2,325.00 | 66,055 | |
| ₩2,400.00 | -90.00 | -3.6% | ₩2,615.00 | ₩2,620.00 | ₩2,400.00 | 41,888 | |
| ₩2,490.00 | -10.00 | -0.4% | ₩2,390.00 | ₩2,575.00 | ₩2,305.00 | 52,600 | |
| ₩2,500.00 | -45.00 | -1.8% | ₩2,545.00 | ₩2,620.00 | ₩2,430.00 | 33,874 | |
| ₩2,545.00 | -35.00 | -1.4% | ₩2,570.00 | ₩2,620.00 | ₩2,545.00 | 8,040 | |
| ₩2,580.00 | +20.00 | +0.8% | ₩2,560.00 | ₩2,675.00 | ₩2,520.00 | 27,070 | |
| ₩2,560.00 | -35.00 | -1.3% | ₩2,685.00 | ₩2,760.00 | ₩2,455.00 | 36,401 | |
| ₩2,595.00 | +15.00 | +0.6% | ₩2,530.00 | ₩2,600.00 | ₩2,530.00 | 29,728 | |
| ₩2,580.00 | -120.00 | -4.4% | ₩2,700.00 | ₩2,760.00 | ₩2,295.00 | 41,324 | |
| ₩2,700.00 | -135.00 | -4.8% | ₩2,765.00 | ₩2,830.00 | ₩2,525.00 | 51,633 | |
| ₩2,835.00 | +40.00 | +1.4% | ₩2,675.00 | ₩2,870.00 | ₩2,675.00 | 83,047 | |
| ₩2,795.00 | +30.00 | +1.1% | ₩2,740.00 | ₩2,895.00 | ₩2,685.00 | 88,592 | |
| ₩2,765.00 | +15.00 | +0.5% | ₩2,730.00 | ₩2,870.00 | ₩2,670.00 | 77,827 | |
| ₩2,750.00 | +170.00 | +6.6% | ₩2,510.00 | ₩2,875.00 | ₩2,510.00 | 146,017 | |
| ₩2,580.00 | +80.00 | +3.2% | ₩2,635.00 | ₩2,660.00 | ₩2,480.00 | 84,861 | |
| ₩2,500.00 | +230.00 | +10.1% | ₩2,335.00 | ₩2,500.00 | ₩2,245.00 | 149,975 | |
| ₩2,270.00 | +25.00 | +1.1% | ₩2,180.00 | ₩2,320.00 | ₩2,045.00 | 61,593 | |
| ₩2,245.00 | +364.00 | +19.4% | ₩1,881.00 | ₩2,340.00 | ₩1,881.00 | 220,350 | |
| ₩1,881.00 | +24.00 | +1.3% | ₩1,819.00 | ₩1,917.00 | ₩1,780.00 | 22,489 | |
| ₩1,857.00 | +13.00 | +0.7% | ₩1,885.00 | ₩1,916.00 | ₩1,805.00 | 17,388 | |
| ₩1,844.00 | +85.00 | +4.8% | ₩1,759.00 | ₩1,856.00 | ₩1,755.00 | 30,007 | |
| ₩1,759.00 | +1.00 | +0.1% | ₩1,824.00 | ₩1,824.00 | ₩1,715.00 | 21,694 | |
| ₩1,758.00 | +203.00 | +13.1% | ₩1,574.00 | ₩1,799.00 | ₩1,574.00 | 108,259 | |
| ₩1,555.00 | +33.00 | +2.2% | ₩1,522.00 | ₩1,624.00 | ₩1,507.00 | 6,191 | |
| ₩1,522.00 | +2.00 | +0.1% | ₩1,548.00 | ₩1,551.00 | ₩1,522.00 | 17,559 | |
| ₩1,520.00 | -29.00 | -1.9% | ₩1,630.00 | ₩1,630.00 | ₩1,520.00 | 9,521 | |
| ₩1,549.00 | -12.00 | -0.8% | ₩1,630.00 | ₩1,630.00 | ₩1,517.00 | 11,688 | |
| ₩1,561.00 | -26.00 | -1.6% | ₩1,587.00 | ₩1,680.00 | ₩1,528.00 | 20,458 | |
| ₩1,587.00 | -5.00 | -0.3% | ₩1,590.00 | ₩1,630.00 | ₩1,550.00 | 26,304 | |
| ₩1,592.00 | -9.00 | -0.6% | ₩1,601.00 | ₩1,614.00 | ₩1,590.00 | 7,342 | |
| ₩1,601.00 | -19.00 | -1.2% | ₩1,620.00 | ₩1,700.00 | ₩1,560.00 | 12,998 | |
| ₩1,620.00 | +4.00 | +0.2% | ₩1,616.00 | ₩1,730.00 | ₩1,603.00 | 10,191 | |
| ₩1,616.00 | -39.00 | -2.4% | ₩1,655.00 | ₩1,705.00 | ₩1,600.00 | 15,817 | |
| ₩1,655.00 | -28.00 | -1.7% | ₩1,683.00 | ₩1,799.00 | ₩1,631.00 | 12,091 | |
| ₩1,683.00 | -72.00 | -4.1% | ₩1,755.00 | ₩1,800.00 | ₩1,649.00 | 14,648 | |
| ₩1,755.00 | -38.00 | -2.1% | ₩1,772.00 | ₩1,849.00 | ₩1,678.00 | 27,276 | |
| ₩1,793.00 | +53.00 | +3.0% | ₩1,977.00 | ₩1,977.00 | ₩1,731.00 | 32,072 | |
| ₩1,740.00 | -10.00 | -0.6% | ₩1,756.00 | ₩1,800.00 | ₩1,740.00 | 13,486 | |
| ₩1,750.00 | -139.00 | -7.4% | ₩1,889.00 | ₩1,889.00 | ₩1,702.00 | 35,910 | |
| ₩1,889.00 | +8.00 | +0.4% | ₩1,865.00 | ₩1,976.00 | ₩1,825.00 | 17,318 | |
| ₩1,881.00 | -57.00 | -2.9% | ₩2,000.00 | ₩2,020.00 | ₩1,877.00 | 43,781 | |
| ₩1,938.00 | -30.00 | -1.5% | ₩1,861.00 | ₩1,984.00 | ₩1,840.00 | 31,367 | |
| ₩1,968.00 | -12.00 | -0.6% | ₩1,901.00 | ₩1,999.00 | ₩1,745.00 | 57,387 | |
| ₩1,980.00 | -10.00 | -0.5% | ₩1,915.00 | ₩2,040.00 | ₩1,851.00 | 65,536 | |
| ₩1,990.00 | +152.00 | +8.3% | ₩1,764.00 | ₩2,000.00 | ₩1,757.00 | 65,252 |
Splits
3 splits since 2023 · KRX:291650 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-2 | Consolidation | |
| 104-for-85 | Split | |
| 2-for-1 | Split |
- Ticker
- KRX:291650
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Aptamer Sciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
EV/sales 8.6× against a median of 3.8×: 5th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩46.37B KRW
- P/E
- Loss
- EV/sales
- 8.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.6×
- Gross margin
- 48.4%
- Operating margin
- −159.1%
- Net margin
- −215.8%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Aptamer Sciences, Inc. · KRX:291650 | US$49.50M | US$34.66M | n/a | 8.6× | n/a | 1.6× | −215.8% | 0.0× | n/a |
| iBio, Inc. · NASDAQ:IBIO | US$51.45M | −US$23.13M | n/a | −21.5× | n/a | 0.7× | n/a | 0.0× | 2.01 |
| Sirnaomics Ltd. · HKEX:2257 | US$51.13M | US$69.20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cinclus Pharma Holding AB · OMXSTO:CINPHA | US$51.07M | US$13.13M | n/a | 3.8× | n/a | 2.6× | −765.8% | 0.0× | n/a |
| Aldeyra Therapeutics, Inc. · NASDAQ:ALDX | US$50.70M | US$9.72M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 0.66 |
| Clene Inc. · NASDAQ:CLNN | US$50.69M | US$58.31M | n/a | 245× | n/a | n/a | n/a | n/a | 1.48 |
| Acrivon Therapeutics, Inc. · NASDAQ:ACRV | US$49.35M | −US$26.60M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.09 |
| SYNTHAVERSE Spolka Akcyjna · GPW:SVE | US$48.68M | US$70.98M | n/a | 5.9× | n/a | 1.7× | −43.1% | 0.8× | n/a |
| Heron Therapeutics, Inc. · NASDAQ:HRTX | US$48.04M | US$156.3M | n/a | 1.1× | n/a | 9.8× | −14.5% | 26.8× | 1.93 |
| Helix BioPharma Corp. · TSX:HBP | US$47.94M | US$50.27M | n/a | n/a | n/a | 4.8× | n/a | 0.3× | 0.36 |
| Oncolytics Biotech Inc. · NASDAQ:ONCY | US$47.66M | US$45.23M | n/a | n/a | n/a | n/a | n/a | n/a | 1.27 |
| Median of the others | US$50.02M | US$47.75M | 3.8× | 1.7× | −43.1% | 0.0× | 1.48 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | May 13, 2026 · Before open | +4.2% |
| Q4 2025 | Mar 17, 2026 · Before open | −4.5% |
| Q3 2025 | Nov 12, 2025 · Before open | +2.2% |
| Q2 2025 | Aug 12, 2025 · Before open | +1.4% |
| Q1 2025 | May 15, 2025 · Before open | −0.4% |
| Q4 2024 | Mar 12, 2025 · After close | −2.5% |
| Q3 2024 | Nov 12, 2024 · After close | −1.1% |
| Q2 2024 | Aug 14, 2024 · After close | +2.0% |
| Q1 2024 | May 16, 2024 · After close | 0.0% |
| Q4 2023 | Mar 28, 2024 · Before open | −1.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2023 | Nov 14, 2023 · After close | +2.0% |
| Q2 2023 | Aug 14, 2023 · After close | −1.1% |
| Q1 2023 | May 15, 2023 · After close | +1.4% |
| Q4 2022 | Mar 22, 2023 · After close | −0.7% |
| Q3 2022 | Nov 14, 2022 · After close | +2.8% |
| Q2 2022 | Aug 16, 2022 · After close | −2.4% |
| Q1 2022 | May 16, 2022 · After close | +2.1% |
| Q4 2021 | Mar 21, 2022 · After close | +1.2% |
| Q3 2021 | Nov 15, 2021 · After close | −2.1% |
| Quarter to Jun 30, 2021 | Aug 17, 2021 · After close | −2.5% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.50B | 1.08B | 243.2M | 358.3M | 269.3M | 228.5M | 407.6M | 276.5M |
| Cost of revenue | 1.81B | 2.72B | 1.86B | 1.58B | 1.35B | 1.20B | 1.21B | 1.21B |
| Gross profit | 1.69B | -1.63B | -1.62B | -1.22B | -1.08B | -974.4M | -802.4M | -934.6M |
| Research and development | 3.36B | 3.14B | 9.36B | 6.03B | 1.76B | 1.77B | ||
| Selling, general and administrative | 2.45B | 1.20B | 810.9M | 700.2M | 709.2M | 828.7M | 726.2M | 469.9M |
| Operating income | -7.80B | -6.87B | -12.2B | -8.32B | -4.07B | -3.92B | -3.29B | -2.69B |
| Depreciation and amortization | 1.11B | 831.7M | 530.4M | 474.7M | 398.8M | 348.1M | 218.9M | 132.6M |
| EBITDA | -6.69B | -6.04B | -11.7B | -7.85B | -3.67B | -3.57B | -3.07B | -2.56B |
| Interest expense | 322.3M | 1.35B | 1.39B | 299.1M | 24.9M | 7.32M | 0 | 0 |
| Income before tax | -8.62B | -8.70B | -13.6B | -8.30B | -3.83B | -3.84B | -3.85B | -6.66B |
| Net income | -8.62B | -8.70B | -13.6B | -7.12B | -3.83B | -3.84B | -3.85B | -6.66B |
| Earnings per share, basic | -428.33 | -297.21 | -801.02 | -357.77 | -226.26 | -453.97 | -273.26 | -1,672.66 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 21.4B | 11.5B | 1.24B | 1.22B | 1.01B | 4.66B | 7.17B | 9.81B |
| Short-term investments | 328.4M | 6.00B | 22.5B | 33.5B | 23.2B | 30.2B | 200.0M | 200.0M |
| Receivables | 781.1M | 631.3M | 24.9M | 271.4M | 14.5M | 5.81M | 12.5M | 7.27M |
| Inventory | 1.51B | 21.3M | 71.5M | 43.6M | 22.4M | 24.5M | 40.8M | |
| Current assets | 25.9B | 18.8B | 25.0B | 38.0B | 24.8B | 35.3B | 7.45B | 10.2B |
| Property, plant and equipment | 11.0B | 7.25B | 7.44B | 7.54B | 735.3M | 542.4M | 477.5M | |
| Goodwill | 37.9M | 961.5M | ||||||
| Total assets | 41.1B | 32.0B | 32.5B | 45.6B | 33.3B | 36.9B | 8.32B | 11.0B |
| Accounts payable | 127.0K | 26.4M | 2.32M | 1.41M | 66.7M | |||
| Current liabilities | 11.8B | 3.89B | 15.2B | 2.54B | 431.7M | 593.3M | 457.2M | 18.0B |
| Long-term debt | 0 | 0 | 6.84B | 0 | 0 | 0 | 5.36B | |
| Total debt | 59.5M | 5.58M | 5.36B | |||||
| Total liabilities | 12.9B | 6.54B | 17.1B | 16.4B | 1.80B | 1.75B | 1.38B | 29.3B |
| Shareholders' equity | 28.2B | 25.4B | 15.5B | 29.2B | 31.5B | 35.2B | 6.94B | -18.3B |
| Shares outstanding | 20.1M | 29.3M | 17.0M | 19.9M | 16.9M | 8.47M | 14.1M | 3.98M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -9.67B | -5.90B | -11.2B | -5.78B | -3.47B | -3.41B | -2.47B | -2.10B |
| Capital spending | -20.5M | -1.14B | -299.8M | -308.9M | -7.09B | -349.4M | -198.0M | -367.8M |
| Free cash flow | -9.69B | -7.04B | -11.5B | -6.08B | -10.6B | -3.78B | -2.67B | -2.47B |
| Cash from investing | 14.2B | 11.3B | -10.7B | -58.0M | -31.1B | -205.1M | 1.06B | |
| Cash from financing | 1.97B | -62.6M | 16.6B | -121.1M | 32.0B | 40.6M | 9.80B | |
| Share buybacks | 17.2B | 287.1M | 0 | 32.1B | 153.3M | 9.86B | ||
| Change in cash | 9.90B | 10.2B | 15.0M | 212.9M | -3.65B | -2.51B | -2.64B | 8.75B |
Cap table
Built by 6ix from Aptamer Sciences, Inc.’s releases
- Common shares
- 30,519,621
- Fully diluted
- 30,519,621
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 30,519,621 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 30,519,621 |
Log in to ask 6ix AI your own questions about Aptamer Sciences, Inc.